Volume 37, Issue 2

Search all Advances in Therapy articles

February 2020

Filter by

Volume:

Sort by

Date published:

New to old Old to new

34 articles in this issue

New Technologies and Applications in Sacral Neuromodulation: An Update
Stefan De Wachter
Charles H. Knowles
Philip E. V. Van Kerrebroeck
Commentary Open access 24 December 2019 Pages: 637 - 643
Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature
André Farkouh
Thomas Riedl
Alexandra Kautzky-Willer
Review 23 December 2019 Pages: 644 - 655
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
Daniel E. Hilleman
Barbara S. Wiggins
Michael B. Bottorff
Review Open access 09 January 2020 Pages: 656 - 670
Analgesic Impact of Single-Shot Versus Continuous Femoral Nerve Block After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis
Shiyi Li
Jinpeng Zhou
Junchao Zhu
Review 10 January 2020 Pages: 671 - 685
Peripheral Vascular Disease and Implication of Nursing Practice: A Brief Literature Review
Qin Fan
Yan Liu
Hongwei Lei
Review 17 January 2020 Pages: 686 - 691
Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists
Laura Grant
Lotte Seiding Larsen
Rob Arbuckle
Review Open access 19 January 2020 Pages: 692 - 706
Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
Yuichi Ohashi
Masahiro Munesue
Fumiki Shimada
Original Research Open access 13 December 2019 Pages: 707 - 717
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma
David J. Jackson
Marc Humbert
Esther Garcia Gil
Original Research Open access 14 December 2019 Pages: 718 - 729
Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
Kirsi M. Manz
Klaus Fenchel
Wolfram C. M. Dempke
Original Research Open access 14 December 2019 Pages: 730 - 744
The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants
Joseph Chen
Huiping Xu
Yazdi K. Pithavala
Original Research 20 December 2019 Pages: 745 - 758
Part of 1 collection:

Early-Phase Clinical Studies
Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib
Nobuyuki Yamamoto
Takeshi Mera
Maximilian J. Hochmair
Original Research Open access 20 December 2019 Pages: 759 - 769
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal
Nermina Ferizović
Jade Marshall
Sheela Upadhyaya
Original Research Open access 21 December 2019 Pages: 770 - 784
Treatment of Atrial Fibrillation Using Ablation Index-Guided Contact Force Ablation: A Matching-Adjusted Indirect Comparison to Cryoballoon Ablation
Ahmed Hussein
Dhiraj Gupta
Giuseppe Stabile
Original Research Open access 21 December 2019 Pages: 785 - 799
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis
Petri Mankinen
Tuomas Lundström
Elina Järvinen
Original Research Open access 23 December 2019 Pages: 800 - 818
A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States
Drishti Shah
Xiaohui Zhao
Usha Sambamoorthi
Original Research Open access 24 December 2019 Pages: 819 - 832
Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study
Maria Antonia González-Henares
Jose Luis Clua-Espuny
Jose Vicente Gil-Guillen
Original Research 26 December 2019 Pages: 833 - 846
Model-Based Cost-Effectiveness Analysis of Panitumumab Plus FOLFIRI for the Second-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer
Yin Shi
Xiaomin Wan
Liubao Peng
Original Research 04 January 2020 Pages: 847 - 859
Screening and Follow-Up of Acute ROP: Reproducibility of Fluorescein Angiography
Donatella Barillà
Rosanna Guagliano
Luciano Quaranta
Original Research 08 January 2020 Pages: 860 - 868
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States
Sarah Naz Ali
Tam Dang-Tan
Brian Bekker Hansen
Original Research Open access 10 January 2020 Pages: 869 - 882
Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries
Jana Podhorna
Nadine Winter
Susann Walda
Original Research Open access 13 January 2020 Pages: 883 - 893
Alzheimer’s Treatment: Real-World Physician Behavior Across Countries
Jana Podhorna
Nadine Winter
Thomas Perkins
Original Research Open access 13 January 2020 Pages: 894 - 905
Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study
Xin Sun
Fangbo Qian
Wen Di
Original Research 16 January 2020 Pages: 906 - 917
Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship
Elizabeth D. Hermsen
Erina L. MacGeorge
Bernard M. Rosof
Original Research Open access 17 January 2020 Pages: 918 - 932
Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database
Maureen J. Lage
Jamie Vora
Ramon Espaillat
Original Research Open access 18 January 2020 Pages: 933 - 945
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors
Eric Nadler
Melissa Pavilack
Ancilla Fernandes
Original Research 18 January 2020 Pages: 946 - 954
Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w
Jinlin Song
Wei Gao
Simran Tiwana
Letter Open access 14 December 2019 Pages: 955 - 957
Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia
Irina Proskorovsky
Erik Vandendries
Matthias Stelljes
Letter Open access 14 December 2019 Pages: 958 - 962
Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”
Aaron Lazorwitz
Christina L. Aquilante
Stephanie Teal
Letter Open access 24 December 2019 Pages: 963 - 964
Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’
Pablo Zubiaur
Miriam Saiz-Rodríguez
Francisco Abad-Santos
Letter Open access 24 December 2019 Pages: 965 - 967
Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small-Cell Lung Cancer in China
Lifeng Mu
Benhong Zhou
Letter Open access 04 January 2020 Pages: 968 - 970
Response Letter to “Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China”
Haijing Guan
Yanan Sheng
Luwen Shi
Letter Open access 04 January 2020 Pages: 971 - 972
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Yehuda Handelsman
Marcel H. A. Muskiet
Graydon S. Meneilly
Correction Open access 23 December 2019 Pages: 973 - 973
Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease
Ariel Berger
Alex Simpson
Jeffrey Berger
Correction 13 January 2020 Pages: 974 - 974
Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
Daphne T. Adelman
Dirk Van Genechten
Wendy A. Martin
Correction Open access 18 January 2020 Pages: 975 - 976

Volume 37, Issue 2

New Technologies and Applications in Sacral Neuromodulation: An Update

Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

Analgesic Impact of Single-Shot Versus Continuous Femoral Nerve Block After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis

Peripheral Vascular Disease and Implication of Nursing Practice: A Brief Literature Review

Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists

Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis

The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants

Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib

Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal

Treatment of Atrial Fibrillation Using Ablation Index-Guided Contact Force Ablation: A Matching-Adjusted Indirect Comparison to Cryoballoon Ablation

Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis

A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States

Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study

Model-Based Cost-Effectiveness Analysis of Panitumumab Plus FOLFIRI for the Second-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

Screening and Follow-Up of Acute ROP: Reproducibility of Fluorescein Angiography

Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study

Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship

Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w

Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”

Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’

Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small-Cell Lung Cancer in China

Response Letter to “Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China”

Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease

Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies

Navigation